Introduction
============

Proliferative diabetic retinopathy (PDR), retinopathy of prematurity (ROP) and retinal vein occlusions are major causes of blindness worldwide, and retinal neovascularization is the key pathogenesis of these ocular diseases [@B1]. Although anti-vascular endothelial growth factor (VEGF) therapies have been applied in those retinal neovascular diseases [@B2], the effect and efficiency is not satisfied in some patients[@B3], and intravitreal injection of anti-VEGF agents may also lead to numerous systemic and local complications, such as tractional retinal detachment, endophthalmitis and acute elevation of blood pressure [@B2], [@B4]. Thus, identification of novel targets that play important roles in retinal neovascularization is urgently needed to treat patients who are not responsible for anti-VEGF therapy.

Long non-coding RNAs (lncRNAs) are more than 200 nucleotides long that function at chromatin organization [@B5], transcriptional and post-transcriptional regulation [@B6]. LncRNAs locate in the nucleus and/or cytoplasm, and are recognized to be expressed in a tissue-specific manner [@B7], indicating that lncRNAs may play crucial regulatory roles in a wide range of biological and pathological processes [@B8]-[@B12]. Moreover, studies have shown that dysregulation of lncRNAs is associated with several ocular diseases, such as diabetic retinopathy [@B13], [@B14], glaucoma [@B15], proliferative vitreoretinopathy [@B16] and retinoblastoma [@B17]. Moreover, targeting some important lncRNAs, such as MIAT [@B14] and MALAT1 [@B18], have been proved to ameliorate pathogenesis of diabetic microvascular complication. Oxygen-induced retinopathy (OIR) is a mouse model which widely used in investigating retinal neovascularization [@B19]-[@B21]. However, the expressions profile and functions of lncRNAs in retinal neovascularization still remain unclear in this model.

In this study, we performed microarray to profile the lncRNAs and mRNAs expression in a mouse model of OIR. Subsequently, we interrogated the putative functions of the altered lncRNA and mRNAs through the *in silico* analysis to reveal the underlying regulatory networks in retinal neovascularization. Our results provide a clue for understanding the potential mechanism of ocular pathological neovascularization on the lncRNA aspect.

Materials and Methods
=====================

Animals and ethics statement
----------------------------

C57BL/6J mice were purchased from Hunan SJA Laboratory Animal Co., Ltd. and were used in all experiments. All of the experimental procedures in the present study were approved by the Institutional Animal Care and Use Committee of Central South University, China. Animals were treated based on the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Oxygen-induced retinopathy mouse model
--------------------------------------

OIR mouse model was induced as previously described [@B19]-[@B21]. In brief, newborn pups were exposed to 75% oxygen at postnatal day 7 (P7), and were returned to room air 5 days later at P12. We used pups kept in room air continuously as the control group. Retinas were collected at P17 in both OIR and room air control mice.

Microarray analysis
-------------------

We isolated total RNA from retinas by using Trizol RNA extraction kit (Invitrogen life technologies). Retinas from both eyes of a mouse were mixed as one sample. The quantification of RNA was assessed by Nano Drop ND-1000, and standard denaturing agarose gel electrophoresis was performed to evaluate RNA integrity. The expression profile of lncRNAs and mRNAs were detected by Arraystar Mouse LncRNA Microarray (V3.0, including 35923 lncRNA and 24881 mRNA transcripts). A total of 6 samples (3 OIR and 3 room air controls) were used for microarray analysis. The tissue preparations and microarray hybridization were performed by using the Agilent Gene Expression Hybridization Kit (Agilent Technology, USA). Acquired array images were analyzed by Feature Extraction software (Agilent Technologies, version 11.0.1.1).

Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR)
--------------------------------------------------------------------------------

Total RNA of 500 ng was reverse-transcripted using RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific, Waltham, MA, USA) and oligo (dT) primers. Quantitative PCR primer sequences are listed in Table [1](#T1){ref-type="table"}. qRT-PCR was conducted on the Applied Biosystems® StepOneTM Plus Real-Time PCR System (Thermo Scientific, Waltham, MA, USA) using FastStart SYBR Green Master (Sigma, St. Louis, MO, USA). Relative quantification data were normalized to β-actin and analyzed by ∆∆Ct method which has been previously described by Livak[@B22].

Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and lncRNAs/mRNAs co-expression network
------------------------------------------------------------------------------------------------------------------------------------

To reveal putative biological changes in mRNA profile and the possible influence of these co-expressed genes and lncRNAs between OIR and control mice, GO analysis (<http://www.geneontology.org>) and KEGG pathway analysis (<http://www.genome.jp/kegg/>) were conducted on altered mRNAs, and the interacted mRNAs within the network.

This coding-non-coding gene co-expression (CNC) network was constructed from 4 validated lncRNAs, and the Pearson correlation coefficients (PCCs) ≥ 0.99 was chosen as the baseline of correlation analysis. Cytoscape V2.8.3 (The Cytoscape Consortium, San Diego, CA, USA) was used to graphically represent the interaction.

Statistical Analyses
--------------------

The statistical difference was assessed by *Student t*-test. Differentially expressed RNAs were identified by fold change (FC)≥2.0 and P\<0.05.

Results
=======

Altered lncRNA and mRNA expression identified in mouse OIR retinas
------------------------------------------------------------------

To investigate the potential difference in retinal lncRNAs and mRNAs expression profile between OIR mice and room air controls, the microarray was performed to detect 35,923 lncRNAs and 24,881 mRNAs transcripts. Our microarray data analysis revealed that 198 and 175 lncRNAs were significantly upregulated and downregulated, respectively in OIR retinas compared to room air controls (FC≥2.0, P\<0.05) (Fig.[1](#F1){ref-type="fig"}A, Supplementary Table [1](#SM0){ref-type="supplementary-material"}). The top 20 most significantly altered (both upregulated and downregulated) lncRNAs are listed in Table [3](#T3){ref-type="table"}-[4](#T4){ref-type="table"}. The hierarchical cluster of heat map (Fig. [1](#F1){ref-type="fig"}C) showed the top 20 significant upregulated and downregulated lncRNAs, and ENSMUST00000153785 and NR_037990 are up- and down-regulated lncRNA transcripts with the most significant changes. Moreover, the hierarchical cluster analysis in Fig. [1](#F1){ref-type="fig"}C suggested successfully classified lncRNAs expression profile among OIR mice and controls.

We also identified that 412 and 127 significantly increased and reduced mRNAs, respectively in OIRs compared to room air controls (fold change≥2.0, P\<0.05) (Fig.[1](#F1){ref-type="fig"}B, Supplementary Table [2](#SM0){ref-type="supplementary-material"}). The top 20 significantly altered (both upregulated and downregulated) lncRNAs are listed in Table [5](#T5){ref-type="table"}-[6](#T6){ref-type="table"}. Among them, edn2 and fmo3 are the up- and downregulated genes with the most significant changes in OIR retinas. Meanwhile, the hierarchical cluster of heat map (Fig. [1](#F1){ref-type="fig"}D) also showed the classification of mRNAs expression profile in the P17 OIR retinas as well.

Validation of differential lncRNAs expression by qRT-PCR and nearby coding gene expression analyses
---------------------------------------------------------------------------------------------------

LncRNAs were selected for qRT-PCR validation from those which have their nearby associated coding genes, and the genomic position of the coding gene is within 300kb upstream or downstream of the altered lncRNA region. Four lncRNAs, ENSMUST00000165968, ENSMUST00000153785, ENSMUST00000134409, and ENSMUST00000154285 were selected to validate the altered lncRNAs in microarray analysis by qRT-PCR. The results showed that the expression of ENSMUST00000165968 and ENSMUST00000153785 was significantly increased to 11.60±3.25-fold and 46.16±13.39-fold in OIR mice (p=0.0173 and p=0.0151, respectively; Fig. [2](#F2){ref-type="fig"}). Likewise, ENSMUST00000134409 and ENSMUST00000154285 were significantly decreased to 0.24±0.024-fold and 0.30±0.093-fold in OIR mice (p\<0.0001 and p=0.0336, respectively; Fig. [2](#F2){ref-type="fig"}). The qRT-PCR results were consistent with the microarray altered expression data in Table [2](#T2){ref-type="table"}. These data suggested the reliability and reproducibility of the lncRNAs expression profile detected by microarray.

To explore the possible role of altered lncRNAs in local regulation of gene expression [@B23], we further analyze the nearby coding gene pairs (distance≤300 kb) based on the genomic information of the validated lncRNAs. We found that the expression level of the lncRNAs\' nearby genes all increased significantly in OIR retina (Table [2](#T2){ref-type="table"}). For example, serpina3 within upstream of ENSMUST00000165968 and FGF2 within the intronic antisense strand of ENSMUST00000153785 were up-regulated in OIR retina compared to control, respectively. Moreover, COL4A2 within upstream of ENSMUST00000134409 and C1QA within downstream of ENSMUST00000154285 showed increased expression levels.

GO enrichment and KEGG pathway analyses on differentially expressed coding genes
--------------------------------------------------------------------------------

All the 539 altered mRNAs underwent GO enrichment analysis and KEGG pathway analysis. The top 10 enriched GO terms on upregulated genes were listed including immune system process (ontology: biological process, GO: 0002376), extracellular region (ontology: cellular component, GO: 0005576) and binding (ontology: molecular function, GO: 0005488) (Fig. [3](#F3){ref-type="fig"}). On the other hand, the top 10 enriched GO term on downregulated genes were listed including sodium-independent organic anion transport (ontology: biological process, GO: 0043252), extracellular region (ontology: cellular component, GO: 0005576) and exopeptidase activity (ontology: molecular function, GO: 0008238) (Fig. [4](#F4){ref-type="fig"}).

KEGG pathway analysis was conducted and demonstrated that the upregulated genes were involved in ECM-receptor interaction, phagosome, PI3K-Akt signaling pathway, and TNF signaling pathway (Fig. [5](#F5){ref-type="fig"}A). While downregulated genes were enriched in the pathways including protein digestion and absorption, vitamin digestion and absorption, and neuroactive ligand-receptor interaction (Fig. [5](#F5){ref-type="fig"}B).

The lncRNA-mRNA co-expression network with GO enrichment and KEGG pathway analyses
----------------------------------------------------------------------------------

CNC network analysis was constructed according to 4 validated differentially expressed lncRNAs with 410 interacted mRNAs. It was composed of 414 nodes (lncRNAs and mRNAs) and 509 edges to connect these nodes, which include 280 positive (continuous lines) and 229 negative (dotted lines) interactions between lncRNAs and mRNAs (Fig. [6](#F6){ref-type="fig"}). Three of the selected 4 lncRNAs (ENSMUST00000165968, ENSMUST00000153785 and ENSMUST00000134409) were connected by mRNAs. In particular, two upregulated lncRNAs, ENSMUST00000165968 and ENSMUST00000153785 were connected by a large number of mRNAs, which demonstrated that these lncRNAs might have more common functional pathways in retinal neovascularization.

In order to predict the functions of the lncRNAs, we performed GO and KEGG pathway analyses of those interacted mRNAs according to the results of the CNC network. The top 10 enriched GO terms on these interacted genes were listed including blood vessel development (ontology: biological process, GO: 0001568), cell part (ontology: cellular component, GO: 0044464) and binding (ontology: molecular function, GO: 0005488) (Fig. [7](#F7){ref-type="fig"}). On the other hand, KEGG pathway analysis showed the top 10 pathways of those interacted mRNAs enriched, including cell adhesion molecules (Fig. [8](#F8){ref-type="fig"}).

Discussion
==========

Previous studies investigated the role of several kinds of molecules and cells in retinal neovascularization by OIR mouse model [@B24]-[@B27]. By using microarray analysis, a study assessed the lncRNA expression profiles in the retina of OIR mice; however, the study only examined lncRNA expression in OIR retinas at P7, P12 and P17, and have not compared the OIR retinas to room air controls at the same time point [@B28]. In the present study, we analyzed the lncRNAs and mRNAs expressions in OIR retinas compared to room air controls at the same age of P17 (the peak of neovascularization [@B19]), which indicated the comparison between disease group and healthy control group.

In the present study, the altered mRNA-based GO enrichment analysis has shed light on the mechanism of retinal neovascularization in OIR. Immune system process [@B29], [@B30] and response to stress [@B31] are well-established factors contributing to the pathogenesis of retinal neovascularization. For example, IL-12 was reported to reduce both avascular areas and neovascular tufts in OIR mice retina through enhancing the expressions of IFN-γ and other downstream chemokines [@B25]. Furthermore, the over-production of reactive oxygen species (ROS) triggered by retinal hypoxia in OIR situation often activates NADPH oxidase, and in turn arouses intravitreal neovascularization by the activation JAK/STAT pathway [@B32], [@B33]. In addition, our results also implicate that some other unreported biological processes such as anion or ion transport were also involved in the retinal neovascularization of OIR mice.

Our pathway analysis on mRNAs suggested some crucial pathogenic mechanisms about retinal neovascularization. For example, a number of studies have shown that vitreous collagen and integrins [@B34], [@B35] provide essential substrates for the preretinal vasculature. This is in line with our findings that upregulated genes were also enriched in the ECM- receptor interaction pathway. Moreover, some other pathways, such as PI3K-Akt signaling pathway [@B36], [@B37], and TNF signaling pathway [@B38] have been widely reported to impact the retinal neovascularization, and were also been enriched in our present study (Fig. [5](#F5){ref-type="fig"}A). We also mentioned some pathways regarding cellular basic processes, including protein digestion and absorption, vitamin digestion and absorption, which indicated that OIR situation would harm the metabolism of the retina.

Our microarray data suggested that several angiogenesis-related genes other than VEGF regulated by lncRNAs, such as collagen type Ⅳ alpha (COL4A)1 and COL4A2, were significantly increased in OIR mice retinas (Supplementary Table [2](#SM0){ref-type="supplementary-material"}). Moreover, COL4A2 is a nearby gene of ENSMUST00000134409 at upstream (Table [2](#T2){ref-type="table"}). It is suggested that spontaneous retinal and subretinal neovascular lesions occurred in *COL4A1* mutant mice, and they proposed that COL4A1 or COL4A2 mutations may lead to higher risk for development of vision- threatening retinopathy [@B39]. Another study reported that patients with *COL4A1* mutation could develop peripheral corneal opacities with corneal neovascularization [@B40]. In addition, COL4A1 or COL4A2 mutations may cause ocular, cerebral, renal and muscular defects, as a result, ophthalmologic examination on retinal vascular tortuosity is recommended to evaluate COL4A1- and COL4A2- mutated cerebrovascular disease [@B41].

Fibroblast growth factor (FGF) 2 is a potent pro-angiogenic factor that has been regarded as a therapeutic target in retinal neovascularization [@B42], and may also be important in the maintenance of neuroretinal function in OIR model [@B43]. In the present study, the gene of FGF2 increased to 2.25-fold (P=0.003) in OIR retinas, and act as the intronic antisense of altered lncRNA ENSMUST00000153785 (Table [2](#T2){ref-type="table"}), which indicated the possible functions of lncRNA in retinal neovascular diseases. Likewise, another gene transforming growth factor-beta (TGFB) 1, which is also involved with retinal neovascularization [@B44], [@B45] was also increased significantly in OIR retinas, which is positively related with upregulated lncRNA ENSMUST00000165968 (Fig. [6](#F6){ref-type="fig"}).

The GO analysis of the CNC network revealed that the interacted genes regulated by altered lncRNAs are mainly involved in blood vessel development, vasculature development and angiogenesis (Fig. [8](#F8){ref-type="fig"}), suggesting that the altered lncRNAs play critical roles in the pathogenesis of retinal neovascularization through regulation of its target genes. Leukocytes play a mediated role in retinal vascular remodeling where leukocytes adhere to the vasculature by CD18 and remodel it by Fas ligand-mediated endothelial cell apoptosis [@B46]. We had previously demonstrated that M2-polarized macrophages were recruited by hypoxia in the inner layer of retinas in the OIR model [@B27]. Our KEGG analysis showed that the interacted genes were enriched in cell adhesion molecules (CAMs) and leukocyte transendothelial migration, indicating that leukocyte including macrophage adhesion molecules might be involved in the mechanisms of pathological retinal neovascularization through lncRNA regulation.

In conclusion, we demonstrated that numerous lncRNAs and mRNAs are significantly altered in the retina of OIR mice compared to control mice. Further, *in silico* analysis indicate that altered lncRNAs were enriched in a variety of biological process that being related to angiogenesis and vasculature development as well as cell adhesion molecules pathway. Our results highlighted that altered lncRNAs and its target genes play important roles in the ischemia-induced retinal angiogenesis however functional assessment of individual lncRNA should be guaranteed in future studies to illustrate their roles in retinal neovascularization.
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![Both lncRNA and mRNA expression profiles were altered in the retinas of mice with oxygen-induced retinopathy (OIR) compared with control retinas. A and B, the volcano plots display the fold-changes and p-values of differential lncRNA (A) and mRNA (B) expression in OIR retinas. Based on the relationship between fold-change and statistical significance, subsets of lncRNAs and mRNAs were isolated. The vertical line corresponds to 2-fold change (up and down), respectively, and the horizontal line represents P=0.05. The red point represents the upregulated lncRNAs or mRNAs with statistical significance P \< 0.05, while the green point represents the significantly decreased lncRNA or mRNA expressions. C and D, the heatmap of the top 20 differentially expressed lncRNAs (C) and mRNAs (D) in OIR groups. Each row represents the relative expression level of a lncRNA or a mRNA, and each column displays the expression level of a retina sample. Colors represent relative intensity of each sample. Red, high relative expression; green, low relative expression; black, no difference.](ijmsv16p0537g001){#F1}

![Validation of differential lncRNA expression by qRT-PCR. Relative expression of lncRNAs ENSMUST00000165968, ENSMUST00000153785, ENSMUST00000134409, and ENSMUST00000154285 in the retina from OIR and control mice was shown. As compared to control, n = 4 for each group. \*, P \< 0.05; \*\*\*, P \< 0.001, *Student t*-test.](ijmsv16p0537g002){#F2}

![The GO analysis of significantly up-regulated mRNAs.](ijmsv16p0537g003){#F3}

![The GO analysis of significantly down-regulated mRNAs.](ijmsv16p0537g004){#F4}

![KEGG pathway analysis of differentially expressed mRNAs. A. The top 10 significant pathways which were correlated with the up-regulated genes. B. The top 9 significant pathways which were correlated with the down-regulated genes.](ijmsv16p0537g005){#F5}

![The lncRNA-mRNA co-expression network. LncRNAs and mRNAs with PCCs≥ 0.99 were selected to construct the network. The network shows the interaction among the lncRNAs and their potential regulated coding genes. Box nodes represent lncRNAs, and circle nodes (green) represent interacted mRNAs. Yellow represents up-regulated lncRNA, and red represents down-regulated lncRNA. Continuous edges show the positive relationship between lncRNAs and mRNAs, while dotted edges describe the inhibitive relationship.](ijmsv16p0537g006){#F6}

![The GO analysis of interacted mRNA by CNC network attributes in the target organism.](ijmsv16p0537g007){#F7}

![KEGG pathway analysis of significant pathways of interacted mRNA by CNC network.](ijmsv16p0537g008){#F8}

###### 

The primer sequences designed for qRT-PCR.

  -----------------------------------------------------------------------------------
  Gene name            Forward and reverse primer               Product length (bp)
  -------------------- ---------------------------------------- ---------------------
  β-actin              F:5\' GTGCTATGTTGCTCTAGACTTCG 3\'\       174
                       R:5\' ATGCCACAGGATTCCATACC 3\'           

  ENSMUST00000165968   F:5\' CAGGATGCAGCAGGTGGAAGC 3\'\         132
                       R:5\' TGCTCCAGGCTGTAGTCTGTGG 3\'         

  ENSMUST00000153785   F:5\' AGGTTCCTCTCCTAGCAGATCATTCTC 3\'\   99
                       R:5\' GAGCGGCAACTTCTGAGGTCTTAC 3\'       

  ENSMUST00000134409   F:5\' GCTGAGTCCTCTTGCTGTGCTC 3\'\        158
                       R:5\' GTACCTGGAGGCTTGGCATGAC 3\'         

  ENSMUST00000154285   F:5\' CCGCTTGGTGGTGCATGTATCC 3\'\        184
                       R:5\' CCAAGGTGCTGAGTGGCTAAGG 3\'         
  -----------------------------------------------------------------------------------

###### 

Validated lncRNAs with significantly altered expression in OIR retinas with their nearby coding mRNA expression.

  lncRNA Name          Nearby Gene   Relationship between lncRNA and nearby gene^a^   lncRNA expression in microarray   mRNA expression in microarray                                            
  -------------------- ------------- ------------------------------------------------ --------------------------------- ------------------------------- -------- -------- ---- ------- --------- --------
  ENSMUST00000165968   Serpina3j     upstream                                         up                                30.11                           0.0004   0.0349   up   3.64    0.0002    0.0178
                       Serpina3i                                                                                                                                               13.93   0.0013    0.0382
                       Serpina3g                                                                                                                                               2.58    0.0020    0.0460
                       Serpina3n                                                                                                                                               21.95   0.0007    0.0300
  ENSMUST00000153785   Fgf2          intronic antisense                               up                                58.30                           0.0007   0.0411   up   2.25    0.0030    0.0526
  ENSMUST00000134409   Col4a2        upstream                                         down                              2.60                            0.0123   0.1240   up   2.20    0.0019    0.0444
  ENSMUST00000154285   C1qa          downstream                                       down                              2.46                            0.0129   0.1267   up   3.23    0.00005   0.0112

a, upstream or downstream, the genomic position of the coding gene is within 300kb upstream or downstream of the differentially expressed lncRNA region. Intronic antisense, the genomic position of the coding gene is located in the antisense strand of lncRNA intron.

###### 

Top 20 upregulated lncRNAs identified by the microarray analysis.

  SeqName              P-value    FDR        Fold Change   Regulation   Strand   Relationship             OIR 1       OIR 2       OIR 3       Control 1   Control 2   Control 3
  -------------------- ---------- ---------- ------------- ------------ -------- ------------------------ ----------- ----------- ----------- ----------- ----------- -----------
  ENSMUST00000153785   0.000717   0.041078   58.296270     up           \-       intronic antisense       12.748014   10.783653   11.958061   6.109738    5.469894    6.314101
  ENSMUST00000165968   0.000409   0.034852   30.109933     up           \-       intergenic               8.449434    6.941674    7.838548    2.890805    2.992069    2.610279
  ENSMUST00000128755   0.004214   0.079423   13.221707     up           \-       exon sense-overlapping   9.614595    7.468352    8.861307    4.748751    5.034332    4.986661
  AK043298             0.015278   0.137199   10.588272     up           \-       intronic antisense       7.422740    4.626696    6.647810    2.720966    2.776193    2.986901
  ENSMUST00000084713   0.015632   0.138298   9.804105      up           \+       natural antisense        8.423589    6.038433    7.642350    3.663067    4.905065    3.656082
  AK044286             0.005517   0.087954   8.824446      up           \-       intergenic               6.588106    5.014738    5.853877    3.387348    2.322640    2.322215
  TCONS_00000098       0.013644   0.130032   7.373443      up           \+       intronic antisense       6.376250    4.062401    5.523742    2.322231    2.322640    2.670507
  AK076995             0.014021   0.132143   7.371760      up           \+       intergenic               13.404888   11.165535   12.681263   9.608284    9.148856    9.848519
  AK002906             0.020071   0.154626   7.029474      up           \-       intronic antisense       7.653271    5.450538    6.973938    4.281011    3.129105    4.227380
  ENSMUST00000109960   0.002150   0.059662   6.769551      up           \+       exon sense-overlapping   8.496722    7.243502    7.930245    4.976211    4.986118    5.430960
  ENSMUST00000124916   0.014606   0.134809   6.111074      up           \+       exon sense-overlapping   7.861429    5.677544    6.847170    4.184352    4.080745    4.286768
  uc007mmy.1           0.008464   0.106702   5.992399      up           \-       intergenic               7.930451    6.101834    7.092284    4.500277    4.299462    4.575429
  ENSMUST00000174161   0.035534   0.197475   5.468632      up           \-       exon sense-overlapping   7.971536    5.525110    6.948038    4.791939    3.697002    4.602203
  uc029vmu.1           0.009057   0.109769   5.298308      up           \-       intergenic               7.293197    5.804285    6.782840    4.464540    3.703680    4.495507
  uc008nps.1           0.003121   0.070411   5.271589      up           \-       exon sense-overlapping   7.488088    6.237517    6.975574    4.357455    4.696039    4.452972
  ENSMUST00000174778   0.004496   0.080692   5.242659      up           \-       intergenic               5.510269    4.239752    4.961743    2.322231    2.896421    2.322215
  ENSMUST00000140000   0.003751   0.074957   5.202250      up           \+       natural antisense        11.112645   9.900810    10.629968   8.155371    7.874338    8.476307
  ENSMUST00000139730   0.003180   0.070468   5.121506      up           \-       exon sense-overlapping   6.917978    5.666435    6.221930    4.070318    3.890004    3.776317
  NR_102319            0.030389   0.184947   5.035999      up           \+       intergenic               8.337279    5.907723    7.444553    4.834966    4.924242    4.933513
  ENSMUST00000128518   0.003024   0.069549   4.980561      up           \+       intronic antisense       11.217601   10.039138   10.746596   8.285136    8.572280    8.196994

Note: FDR: false discovery rate; Fold change: the absolute ratio (no log scale) of average normalized intensities between two groups (Control vs OIR); OIR 1-3 and Control 1-3: each sample\'s normalized intensity (log2 scale). Similarly hereinafter.

###### 

Top 20 downregulated lncRNAs identified by the microarray analysis.

  SeqName              P-value    FDR        Fold Change   Regulation   Strand   Relationship               OIR 1      OIR 2      OIR 3      Control 1   Control 2   Control 3
  -------------------- ---------- ---------- ------------- ------------ -------- -------------------------- ---------- ---------- ---------- ----------- ----------- -----------
  NR_037990            0.002930   0.068842   9.133963      down         \-       intergenic                 6.496983   8.179386   7.582079   10.578837   10.609151   10.644182
  TCONS_00002350       0.001018   0.044913   5.122573      down         \-       intergenic                 3.398719   3.932456   4.328286   6.167787    6.210308    6.351972
  ENSMUST00000144657   0.000003   0.005941   5.077183      down         \-       intergenic                 3.286124   3.147485   3.127405   5.459278    5.546184    5.587637
  ENSMUST00000151134   0.000340   0.033792   4.954950      down         \+       exon sense-overlapping     5.979015   5.713499   5.694462   8.139835    7.774910    8.398843
  TCONS_00032380       0.034449   0.195020   4.527209      down         \+       intergenic                 2.325546   4.667767   3.856036   5.671859    5.771139    5.942216
  uc007gkn.1           0.001968   0.057266   4.089872      down         \-       intergenic                 4.373150   5.274554   5.118756   6.920329    6.895577    7.046721
  ENSMUST00000172432   0.002383   0.062812   4.076810      down         \+       exon sense-overlapping     7.235149   8.230403   7.929420   9.829141    9.772890    9.875263
  ENSMUST00000138379   0.016487   0.142047   3.963568      down         \-       intergenic                 3.852936   5.523289   4.670400   6.755349    6.409639    6.842036
  AK033442             0.003089   0.070273   3.946389      down         \+       intergenic                 4.226163   4.571180   3.525945   6.125788    6.133114    6.005986
  uc007qgm.1           0.011972   0.123334   3.800768      down         \-       intergenic                 3.220853   4.704746   3.926131   5.841821    5.717811    6.070972
  uc008juf.1           0.000020   0.012523   3.701798      down         \+       natural antisense          4.666801   4.596779   4.770185   6.444632    6.660882    6.592930
  ENSMUST00000101535   0.000009   0.009977   3.691835      down         \-       bidirectional              2.325546   2.384761   2.322128   4.222979    4.121313    4.341157
  uc007gxl.1           0.001245   0.048164   3.582029      down         \+       intergenic                 2.774715   3.120723   2.579922   4.422965    4.601643    4.973084
  AK051599             0.000514   0.036142   3.544961      down         \-       intergenic                 5.247084   4.775668   4.983758   6.846470    6.620034    7.017314
  TCONS_00012126       0.001979   0.057322   3.538878      down         \+       intronic antisense         2.325546   3.137978   2.842555   4.746606    4.590341    4.439007
  ENSMUST00000161581   0.001803   0.055911   3.535215      down         \+       intronic antisense         4.429070   5.057126   4.958622   6.669437    6.881586    6.359189
  NR_045837            0.005624   0.089054   3.459985      down         \+       intergenic                 2.325546   3.143285   2.710571   4.403620    4.185882    4.962196
  AK044715             0.000682   0.040064   3.358611      down         \+       intronic antisense         5.603129   6.181402   6.033230   7.678702    7.586453    7.796200
  NR_045643            0.007305   0.100085   3.344530      down         \-       intron sense-overlapping   8.272287   9.375150   8.883848   10.638966   10.331851   10.785879
  uc008qwo.1           0.004288   0.079723   3.282559      down         \-       intronic antisense         4.425972   3.572821   4.425015   5.793922    5.771023    6.003325

###### 

Top 20 upregulated mRNAs identified by the microarray analysis.

  SeqName        Gene Symbol   P-value    Fold Change   Regulation   Chrom   OIR 1       OIR 2       OIR 3       Control 1   Control 2   Control 3
  -------------- ------------- ---------- ------------- ------------ ------- ----------- ----------- ----------- ----------- ----------- -----------
  NM_007902      Edn2          0.000205   67.381397     up           chr4    11.852624   10.303807   11.289775   4.877096    5.045049    5.301226
  NM_009252      Serpina3n     0.000737   21.945872     up           chr12   9.307844    7.668389    8.591409    4.155878    3.957815    4.086316
  NM_021274      Cxcl10        0.012493   20.920455     up           chr5    10.216826   6.826442    9.337704    4.328950    4.440061    4.451434
  NM_009264      Sprr1a        0.000364   18.752312     up           chr3    10.062212   8.794292    9.433780    5.356192    5.026828    5.220274
  NM_133664      Lad1          0.002447   18.169869     up           chr1    7.659905    6.033975    7.007441    3.506036    2.322640    2.322215
  NM_011333      Ccl2          0.008392   17.072770     up           chr11   10.247771   7.412768    9.424877    4.785440    4.976798    5.042302
  NM_001130176   Tnnt2         0.003248   15.923864     up           chr1    10.822550   8.708082    10.084477   5.902835    6.098196    5.634722
  NM_001199940   Serpina3i     0.001304   13.928220     up           chr12   8.721851    7.263056    8.195904    4.538610    4.381300    3.861084
  NM_029796      Lrg1          0.023929   13.268675     up           chr17   8.218846    4.754638    6.925944    3.403098    2.920299    2.386174
  NM_010277      Gfap          0.000579   12.789066     up           chr11   15.814435   14.657697   15.289936   11.587811   11.295535   11.848205
  NM_011313      S100a6        0.001415   11.725444     up           chr3    12.736235   11.184588   12.090365   8.514794    8.378681    8.463001
  NM_007742      Col1a1        0.000404   11.093194     up           chr11   7.350857    6.503708    6.813182    3.296546    3.810072    3.146321
  NM_009627      Adm           0.001672   10.740590     up           chr7    9.376728    7.938694    8.770966    5.289006    5.578209    4.944169
  NM_007807      Cybb          0.000520   9.827009      up           chrX    6.284053    5.254420    5.689879    2.322231    2.693649    2.322215
  NM_008491      Lcn2          0.001927   9.274859      up           chr2    10.781325   9.284550    10.217709   6.831314    7.035850    6.776445
  NM_009364      Tfpi2         0.004769   9.134172      up           chr6    9.771275    7.940594    9.080595    5.493661    5.638994    6.085987
  NM_177448      Mogat2        0.000197   9.117081      up           chr7    7.704113    6.972424    7.414555    3.980103    4.155026    4.390246
  NM_177868      Fhad1         0.006403   8.921200      up           chr4    9.166995    7.314457    8.454878    5.459930    5.392350    4.612338
  NM_017372      Lyz2          0.000032   8.909107      up           chr10   9.377222    8.941198    9.078166    5.838286    5.975234    6.117223
  NM_001204910   AI607873      0.001438   8.888613      up           chr1    8.415281    7.072290    7.920147    4.528947    4.592748    4.830148

###### 

Top 20 downregulated mRNAs identified by the microarray analysis.

  SeqName              Gene Symbol     P-value    Fold Change   Regulation   Chrom   OIR 1      OIR 2       OIR 3      Control 1   Control 2   Control 3
  -------------------- --------------- ---------- ------------- ------------ ------- ---------- ----------- ---------- ----------- ----------- -----------
  NM_008030            Fmo3            0.000064   16.284224     down         chr1    2.825890   2.364353    3.137431   6.911447    6.719705    6.772731
  NM_008657            Myf6            0.000256   6.457197      down         chr10   4.612338   5.304050    5.222832   7.700051    7.722884    7.789008
  NM_175497            Actbl2          0.005672   5.932106      down         chr13   2.325546   3.940411    3.371026   5.865282    5.703255    5.774079
  NM_001033360         Gpr101          0.000516   5.585098      down         chrX    5.267588   6.034113    5.634033   8.066730    7.992215    8.321536
  NM_175678            Npsr1           0.000091   5.447918      down         chr9    4.373860   4.804202    4.524192   7.082227    6.838859    7.118283
  ENSMUST00000113172   Gm7903          0.003727   4.876647      down         chrX    2.325546   3.421091    2.322128   4.864159    5.154450    4.907825
  NM_009363            Tff2            0.027743   4.556195      down         chr17   3.511692   5.727574    4.891790   6.904248    6.953879    6.836418
  NM_031402            Crispld1        0.000284   4.285419      down         chr1    5.009625   5.520657    5.393212   7.386189    7.269699    7.565915
  NM_001168423         Spink13         0.000095   4.155850      down         chr18   7.918376   8.298454    7.956590   10.150014   10.016010   10.172827
  NM_027174            Col22a1         0.000099   3.989103      down         chr15   6.579486   6.996267    6.898594   8.816916    8.862802    8.782823
  NM_183320            Gm5128          0.000218   3.909112      down         chrX    2.325546   2.784199    2.322128   4.435049    4.475323    4.422023
  NM_023624            Lrat            0.007738   3.690353      down         chr3    8.957304   10.177897   9.685661   11.532595   11.234553   11.704990
  NM_008469            Krt15           0.001462   3.582905      down         chr11   6.272760   7.090776    6.681673   8.530754    8.508751    8.529093
  NM_023774            4930550L24Rik   0.001266   3.519266      down         chrX    3.887049   4.602469    4.240050   5.997637    5.947053    6.230702
  NM_029993            Mlana           0.001245   3.515738      down         chr19   5.456453   6.205720    5.873087   7.599213    7.764418    7.613112
  NM_009827            Cckar           0.001693   3.481647      down         chr5    4.075800   4.090868    3.695177   5.778705    5.391791    6.090659
  NM_025357            Smpx            0.000191   3.458745      down         chrX    2.325546   2.764756    2.542606   4.297434    4.275888    4.430330
  NM_152802            Defb12          0.003577   3.430810      down         chr8    3.179997   3.787608    2.912021   5.212757    4.811799    5.190719
  NM_028526            Pebp4           0.000152   3.406140      down         chr14   2.325546   2.322138    2.322128   3.930714    4.340979    4.002533
  NM_011887            Scn11a          0.000002   3.304723      down         chr9    6.678956   6.791706    6.766182   8.453526    8.449595    8.507312
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